Previous Close | 0.0600 |
Open | 0.0600 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 95.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.0600 - 0.0600 |
Contract Range | N/A |
Volume | |
Open Interest | 271 |
“We believe earnings growth is set for a healthier runway through 2024,” Morgan Stanley’s analysts wrote.
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.